Jazz Pharmaceuticals(JAZZ) - 2024 Q4 - Earnings Call Presentation

February 25, 2025 2024 Fourth Quarter and Full Year Financial Results Innovating to Transform the Lives of Patients and Their Families EPIDIOLEX® patient diagnosed with Dravet syndrome February 25, 2025 Markella Transforming Lives. Redefining Possibilities. Caution Concerning Forward-Looking Statements This presentation contains forward-looking statements and financial targets, including, but not limited to, statements related to: the Company's growth prospects and future financial and operating results, in ...